Systemic steroids in the treatment of psoriasis: What is fact, what is fiction?

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 8, 2013, Pages 1022-1025

  Mrowietz, U ^a,b   Domm, S ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISOLONE ACETATE; PREDNISONE; STEROID; TRIAMCINOLONE; TRIAMCINOLONE DIACETATE;

ARTICLE; ASTHMA; CAUCASIAN; COMPARATIVE EFFECTIVENESS; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG EFFICACY; HUMAN; INCIDENCE; MEDICAL HISTORY; META ANALYSIS (TOPIC); PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; REBOUND; STEROID THERAPY; SYSTEMIC THERAPY;

ADRENAL CORTEX HORMONES; HUMANS; PSORIASIS;

EID: 84880511914     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04656.x     Document Type: Article

References (33)

1. Nast A, Boehncke WH, Mrowietz U, et al. S3-guidelines for the treatment of psoriasis vulgaris Update 2011. J Dtsch Dermatol Ges 2011; 9: S1-104.
2. Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23: 1-70.
3. Augustin M, Schäfer I, Reich K, et al. Systemic treatment with corticosteroids in psoriasis - health care provision far beyond the S3-guidelines. J Dtsch Dermatol Ges 2011; 9: 833-838.
4. Brenner M, Molin S, Ruebsam K, et al. Generalized pustular psoriasis induced by systemic glucocorticosteroids: four cases and recommendations for treatment. Br J Dermatol 2009; 161: 964-966.
5. Baker H, Ryan TJ,. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol 1968; 80: 771-793.
6. Augey F, Dissard C, Normand I, Daumont M,. Generalized pustular psoriasis (von Zumbusch) following iatrogenic hypocortisolism. Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis. Eur J Dermatol 2004; 14: 415-417.
7. Hellgren L,. Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis. Ann Clin Res 1976; 8: 317-319.
8. Brodell RT, Williams L,. A corticosteroid-induced flare of psoriasis. How to control or, better yet, avoid. Postgrad Med 1999; 106: 31-32.
9. Cohen D, Distelheim IH,. Generalized erythrodermia occurring in a case of psoriasis on treatment with adrenocorticotropic hormone (ACTH). J Invest Dermatol 1951; 17: 61-63.
10. Zaun H,. Some data on the influence of factors unrelated to therapy on the healing time in an attack of psoriasis. Hautarzt 1973; 24: 189-193.
11. Lindgren S, Groth O,. Generalized pustular psoriasis. A report on thirteen patients. Acta Derm Venereol 1976; 56: 139-147.
12. Zaun H,. Oral glucocorticosteroid therapy in psoriasis vulgaris: pro and con. Hautarzt 1985; 36: 13-15.
13. Baker H,. Corticosteroids and pustular psoriasis. Br J Dermatol 1976; 94: 83-88.
14. Agache P, Barale T, Bonjean JM,. New types of pustular psoriasis. Arch Belg Dermatol Syphiligr 1970; 26: 115-128.
15. Marsden CW,. Oral steroid therapy in psoriasis vulgaris. A comparison of triamcinolone, methyl prednisolone and dexamethasone. Br J Dermatol 1961; 73: 103-106.
16. Fergusson AG, Dewar WA,. Observations on steroid therapy in psoriasis. Br J Dermatol 1957; 69: 57-60.
17. Shelly WB, Haru JS, Pillsbury DM,. The treatment of psoriasis and other dermatoses with triamcinolone (aristocort). J Am Med Assoc 1958; 167: 659-664.
18. Hollander JL, Brown EM Jr, Jessar RA, et al. The effect of triamcinolone on psoriatic arthritis-a two year study. Arthritis Rheum 1959; 2: 513-525.
19. Walch J,. Treatment of psoriasis with 9 alpha-fluoro-16 alpha-hydroxy-prednisolone. Dermatologic 1959; 118: 244-248.
20. Cohen HJ, Baer RL,. Triamcinolone and methyl prednisolone in psoriasis. Comparison of their intralesional and systemic effects. J Invest Dermatol 1960; 34: 271-275.
21. Chowaniec O, Blichowska T,. Case of generalized pustular psoriasis caused by corticosteroid treatment of simple psoriasis and pemphigus. Przegl Dermatol 1979; 66: 541-544.
22. Gschnait F, Konrad K, Hönigsmann H, Wolff K,. Photochemotherapie bei kortikosteroid- und methotrexatbehandelten Psoriatikern. Hautarzt 1977; 28: 632-637.
23. Boyd AS, Menter A,. Erythrodermic psoriasis. Precipitating factors, course, and prognosis in 50 patients. J Am Acad Dermatol 1989; 21: 985-991.
24. Zachariae H,. Innere Behandlung der Psoriasis-Eine Übersicht. Hautarzt 1976; 27: 569-573.
25. Ritchlin CT, Kavanaugh A, Gladman DD, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009; 68: 1387-1394.
26. Gossec L, Smolen JS, Gaujaux-Viala C, et al. European league against rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis 2012; 71: 4-12.
27. Bernstein CN, Wajda A, Blanchard JF,. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005; 129: 827-836.
28. Smits NA, Duru N, Bijlsma JW, Jacobs JW,. Adverse events of intravenous glucocorticoid pulse therapy in inflammatory diseases: a meta-analysis. Clin Exp Rheumatol 2011; 29: S85-S92.
29. Hoes JN, Jacobs JW, Verstappen SM, et al. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis. Ann Rheum Dis 2009; 68: 1833-1838.
30. Thaller V, Vrkljan M, Hotujac L, Thakore J,. The potential role of hypocortisolism in the pathophysiology of PTSD and psoriasis. Coll Antropol 1999; 23: 611-619.
31. Lind M,. Cure of Psoriasis and Arthritis when Addison's disease was detected. Case Rep Dermatol 2010; 2: 95-98.
32. Atzeni F, Sarzi-Puttini P, DePortu S, et al. In etanercept-treated psoriatic arthritis patients clinical improvement correlated with an increase of serum cortisol relative to other adrenal hormones. Clin Exp Rheumatol 2008; 26: 103-108.
33. Hoes JN, Jacobs JW, Buttgereit F, Bijlsma JW,. Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis. Nat Rev Rheumatol 2010; 6: 693-702.